Literature DB >> 28150432

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Antonio P Strafella1, Nicolaas I Bohnen2, Joel S Perlmutter3, David Eidelberg4, Nicola Pavese5, Thilo Van Eimeren6, Paola Piccini7, Marios Politis8, Stephane Thobois9, Roberto Ceravolo10, Makoto Higuchi11, Valtteri Kaasinen12, Mario Masellis13, M Cecilia Peralta14, Ignacio Obeso15, Jose Ángel Pineda-Pardo15, Roberto Cilia16, Benedicte Ballanger17, Martin Niethammer4, Jon A Stoessl18.   

Abstract

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  FDG; PET; Parkinson's disease; acetylcholine; amyloid; atypical parkinsonism; dopamine; serotonin; tau

Mesh：

Year:  2017        PMID： 28150432     DOI： 10.1002/mds.26907

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  29 in total

1.  Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.

Authors:  Valtteri Kaasinen; Tuomas Kankare; Juho Joutsa; Tero Vahlberg
Journal:  J Nucl Med       Date:  2019-04-12       Impact factor: 10.057

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 3.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

Review 4.  Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Authors:  Cecilia Peralta; Federico Biafore; Tamara Soto Depetris; Maria Bastianello
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-29       Impact factor: 5.081

5.  Use of deep learning-based radiomics to differentiate Parkinson's disease patients from normal controls: a study based on [18F]FDG PET imaging.

Authors:  Xiaoming Sun; Jingjie Ge; Lanlan Li; Qi Zhang; Wei Lin; Yue Chen; Ping Wu; Likun Yang; Chuantao Zuo; Jiehui Jiang
Journal:  Eur Radiol       Date:  2022-06-08       Impact factor: 5.315

Review 6.  Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens.

Authors:  Peili Cen; Youyou Zhou; Chunyi Cui; Yen Wei; Zhen Cheng; Shuizhu Wu; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-04       Impact factor: 9.236

Review 7.  Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Authors:  Cecilia Peralta; Antonio P Strafella; Thilo van Eimeren; Roberto Ceravolo; Klaus Seppi; Valtteri Kaasinen; Julieta E Arena; Stephane Lehericy
Journal:  Mov Disord Clin Pract       Date:  2021-11-15

Review 8.  Research progress in the early diagnosis of Parkinson's disease.

Authors:  LinLin Xie; LuDong Hu
Journal:  Neurol Sci       Date:  2022-08-11       Impact factor: 3.830

Review 9.  Challenges in the diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Alicia Garrido; Sonja W Scholz; Werner Poewe
Journal:  Lancet Neurol       Date:  2021-05       Impact factor: 44.182

Review 10.  Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?

Authors:  Lana M Chahine; Matthew B Stern
Journal:  Mov Disord Clin Pract       Date:  2017-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.